BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30146991)

  • 1. Improving Rural Access to Opioid Treatment Programs.
    Johnson Q; Mund B; Joudrey PJ
    J Law Med Ethics; 2018 Jun; 46(2):437-439. PubMed ID: 30146991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 3. Access to treatment for opioid dependence in rural America: challenges and future directions.
    Sigmon SC
    JAMA Psychiatry; 2014 Apr; 71(4):359-60. PubMed ID: 24500040
    [No Abstract]   [Full Text] [Related]  

  • 4. Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States.
    Davis CS; Carr DH
    Int J Drug Policy; 2019 Nov; 73():42-48. PubMed ID: 31336293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicines for Patients After an Opioid Overdose.
    Ann Intern Med; 2018 Aug; 169(3):. PubMed ID: 29913484
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment.
    Havens JR; Walsh SL; Korthuis PT; Fiellin DA
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):315-323. PubMed ID: 29948609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
    Andrilla CHA; Coulthard C; Larson EH
    Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical specialty of buprenorphine prescribers for pregnant women with opioid use disorder.
    Hollander MAG; Jarlenski MP; Donohue JM; Cole ES; Kelley D; Krans EE
    Am J Obstet Gynecol; 2019 May; 220(5):502-503. PubMed ID: 30703340
    [No Abstract]   [Full Text] [Related]  

  • 9. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
    Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
    Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between buprenorphine provider availability and opioid deaths among US counties.
    Jones CW; Christman Z; Smith CM; Safferman MR; Salzman M; Baston K; Haroz R
    J Subst Abuse Treat; 2018 Oct; 93():19-25. PubMed ID: 30126537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone and prescription drug overdose.
    Hendrikson H; Hansen M
    NCSL Legisbrief; 2014 Dec; 22(45):1-2. PubMed ID: 25556261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior.
    Mitchell P; Samsel S; Curtin KM; Price A; Turner D; Tramp R; Hudnall M; Parton J; Lewis D
    Soc Sci Med; 2022 Jun; 302():114992. PubMed ID: 35512612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staring down the opioid epidemic.
    Unger JR
    J Fam Pract; 2017 Jan; 66(1):8. PubMed ID: 28188310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
    Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
    JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Use Disorder and Pregnancy.
    O'Donnell FT; Jackson DL
    Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission.
    Bachireddy C; Weisberg DF; Altice FL
    Addiction; 2015 Dec; 110(12):1869-71. PubMed ID: 26464200
    [No Abstract]   [Full Text] [Related]  

  • 18. Barriers to accessing opioid agonist therapy in pregnancy.
    Bedrick BS; O'Donnell C; Marx CM; Friedman H; Carter EB; Stout MJ; Kelly JC
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100225. PubMed ID: 33345932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction).
    Suen LW; Incze M; Simon C; Englander H; Bratberg J; Groves Scott G; Winograd R
    Subst Use Addctn J; 2024 Jul; 45(3):337-345. PubMed ID: 38804606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas.
    Meyer M; Phillips J
    Prev Med; 2015 Nov; 80():18-22. PubMed ID: 26212632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.